✦ LIBER ✦

372 A phase I dose-escalation study of the fully human monoclonal antibody MNRP1685A (anti-NRP1) administered intravenously to patients with advanced solid tumors

✍ Scribed by C. Weekes; P. Hedge; Y. Xin; R. Yu; H. Xiang; L. Gore; M. Beeram; R. Brachmann; A. Patnaik

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of the human monoclonal

✍ Weekes, Colin D.; Beeram, Muralidhar; Tolcher, Anthony W.; Papadopoulos, Kyriako 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 387 KB

A Phase Ib study evaluating MNRP1685A, a

✍ Patnaik, Amita; LoRusso, Patricia M.; Messersmith, Wells A.; Papadopoulos, Kyria 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 425 KB

28 A First-in-human Phase I Study to Eva

✍ Smith, D.C.; Chugh, R.; Patnaik, A.; Papadopoulos, K.; Chambers, G.; Thorpe, V.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 75 KB

166 A phase I dose-escalation study of a

✍ A. Ricart; G. Liu; A. Tolcher; G. Schwartz; J. Harris; R. Stagg; E. Rowinsky; G. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 297 KB

A phase 1 study of lucatumumab, a fully

✍ William Bensinger; Richard T. Maziarz; Sundar Jagannath; Andrew Spencer; Simon D 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

723 POSTER A phase I dose-escalation stu

✍ T. Doi; A. Ohtsu; K. Nakagawa; I. Okamoto; K. Kurei; K. Kobayashi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 69 KB